SCHEMBL4191013

SCHEMBL4191013

C[C@@H](CC1CCCC1)NC(=O)c1ccccc1NS(=O)(=O)c1cccs1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.49
MEN1 O00255 5/20 0.49
KMT2A Q03164 5/20 0.49
KDM4E B2RXH2 4/20 0.49
HPGD P15428 3/20 0.49
GAA P10253 2/20 0.49
POLB P06746 2/20 0.49
HSD17B10 Q99714 1/20 0.49
NPC1 O15118 1/20 0.48
MAPT P10636 6/20 0.43
HTT P42858 2/20 0.43
PKM P14618 2/20 0.43
MCL1 Q07820 1/20 0.43
BCL2A1 Q16548 1/20 0.43
MCOLN3 Q8TDD5 1/20 0.43
LMNA P02545 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4198023 0.99 ALDH1A1 (0.48) ALDH1A1MEN1KMT2AKDM4EHPGD
SCHEMBL4195126 0.82 NPC1 (0.44) ALDH1A1MEN1KMT2AKDM4EGAA
SCHEMBL4707205 0.80 ALDH1A1 (0.49) ALDH1A1MEN1KMT2AKDM4EHPGD
SCHEMBL4199654 0.80 NPC1 (0.50) ALDH1A1MEN1KMT2AKDM4EHPGD
SCHEMBL4708553 0.79 ALDH1A1 (0.48) ALDH1A1MEN1KMT2AKDM4EHPGD
SCHEMBL4198105 0.79 NPC1 (0.49) ALDH1A1MEN1KMT2AKDM4EHPGD
SCHEMBL12435747 0.75 ALDH1A1 (0.63) ALDH1A1MEN1KMT2AKDM4EHPGD
SCHEMBL5616176 0.75 KCNA5 (0.72) ALDH1A1MEN1KMT2AKDM4EHPGD
SCHEMBL5075500 0.75 KCNA5 (0.72) ALDH1A1MEN1KMT2AKDM4EHPGD
SCHEMBL4189902 0.75 NPC1 (0.45) ALDH1A1KDM4EHPGDGAANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP claimed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US claimed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US claimed
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP disclosed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US disclosed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215764-A1 Antimicrobial agents TUFM, RPS17, HARS1 ALDH1A1 2744/4885MEN1 3776/4885KMT2A 2047/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.